Bayer | BAYN - Equity Capital And Reserves

Stock Price
36.62
Daily Change
-1.76 -4.59%
Monthly
-6.26%
Yearly
58.05%
Q2 Forecast
37.49

Bayer reported EUR25.95B in Equity Capital and Reserves for its fiscal quarter ending in December of 2025.





Equity Capital And Reserves Change Date
Air Liquide EUR 26.21B 1.7B Dec/2025
Akzo Nobel EUR 4.88B 222M Mar/2026
Alcon AG USD 22.03B 52M Dec/2025
Amarin USD 459.28M 387K Dec/2025
Arkema EUR 6.04B 78M Dec/2025
AstraZeneca USD 48.67B 2.78B Dec/2025
BASF EUR 33.2B 434M Dec/2025
Bayer EUR 25.95B 3.75B Dec/2025
Beiersdorf EUR 8.6B 133M Dec/2025
Corteva USD 24.14B 1.08B Dec/2025
Covestro EUR 7B 908M Dec/2025
Essilor EUR 38.89B 1.07B Dec/2025
Fresenius EUR 18.62B 320M Sep/2025
Fresenius Medical Care EUR 249.82M 12.7B Dec/2025
Genmab DKK 5.85B 96M Dec/2025
Givaudan CHF 4.54B 430M Dec/2025
GlaxoSmithKline GBP 16.38B 229M Dec/2025
GRIFOLS EUR 5.29B 108.05M Dec/2025
Henkel EUR 20.5B 459M Dec/2025
Hikma Pharmaceutical USD 2.59B 42M Dec/2025
Johnson Matthey GBP 2.1B 194M Dec/2025
Linde USD 38.25B 1.84B Dec/2025
Lonza CHF 9.13B 513M Dec/2025
Merck EUR 28.59B 344M Dec/2025
Novartis USD 46.13B 1.38B Dec/2025
Nutrien USD 25.32B 206M Dec/2025
Philips EUR 10.58B 204M Sep/2025
PPG Industries USD 7.94B 141M Dec/2025
Roche Holding CHF 33.8B 758M Dec/2025
Sanofi EUR 72.81B 1.1B Mar/2026
SAP EUR 44.86B 109M Mar/2026
Solvay EUR 1.02B 245M Dec/2025
UCB EUR 10.87B 1.18B Dec/2025
Umicore EUR 2.24B 195.4M Dec/2025
Vinci EUR 34.33B 5.71B Dec/2025